Integrative Clinical Genomics of Advanced Prostate Cancer
2015; Cell Press; Volume: 162; Issue: 2 Linguagem: Inglês
10.1016/j.cell.2015.06.053
ISSN1097-4172
AutoresDan R. Robinson, Eliezer M. Van Allen, Yi‐Mi Wu, Nikolaus Schultz, Robert J. Lonigro, Juan‐Miguel Mosquera, Bruce Montgomery, Mary‐Ellen Taplin, Colin C. Pritchard, Gerhardt Attard, Himisha Beltran, Wassim Abida, Robert K. Bradley, Jake Vinson, Xuhong Cao, Pankaj Vats, Lakshmi P. Kunju, Maha Hussain, Felix Y. Feng, Scott A. Tomlins, Kathleen A. Cooney, David C. Smith, Christine Brennan, Javed Siddiqui, Rohit Mehra, Yu Chen, Dana E. Rathkopf, Michael J. Morris, Stephen B. Solomon, Jeremy C. Durack, Victor E. Reuter, Anuradha Gopalan, Jianjiong Gao, Massimo Loda, Rosina T. Lis, Michaela Bowden, Stephen Balk, Glenn C. Gaviola, Carrie Sougnez, Manaswi Gupta, Evan Y. Yu, Elahe A. Mostaghel, Heather H. Cheng, Hyojeong Mulcahy, Lawrence D. True, Stephen R. Plymate, Heidi Dvinge, Roberta Ferraldeschi, Penny Flohr, Susana Miranda, Zafeiris Zafeiriou, Nina Tunariu, Joaquı́n Mateo, Raquel Pérez-López, Francesca Demichelis, Brian D. Robinson, Andrea Sboner, Marc Schiffman, David M. Nanus, Scott T. Tagawa, Alexandros Sigaras, Kenneth Eng, Olivier Elemento, Andrea Sboner, Elisabeth I. Heath, Howard I. Scher, Kenneth J. Pienta, Philip W. Kantoff, Johann S. de Bono, Mark A. Rubin, Peter S. Nelson, Levi A. Garraway, Charles L. Sawyers, Arul M. Chinnaiyan,
Tópico(s)Cancer Genomics and Diagnostics
Resumo(Cell 161, 1215–1228; May 21, 2015) Our paper presented an integrated sequencing analysis of clinical samples from advance prostate cancer patients. Parts of the findings were listed in Table S3, Mutations Identified in the 150 Cases. During the preparation of our table, we inadvertently mislabeled three gene names. In row 14118, 11-Sep should be SEPT11. In row 22306, 12-Sep should be SEPT12. In row 22927, 1-Mar should be MARCH1. These errors do not affect any conclusions of the paper, and the corrected version of Table S3 has been updated online. We apologize for any inconvenience this may have caused. Integrative Clinical Genomics of Advanced Prostate CancerRobinson et al.CellMay 21, 2015In BriefA multi-institutional integrative clinical sequencing analysis reveals that the majority of affected individuals with metastatic castration-resistant prostate cancer harbor clinically actionable molecular alterations, highlighting the need for genetic counseling to inform precision medicine in affected individuals with advanced prostate cancer. Full-Text PDF Open Archive
Referência(s)